To compare different drugs like dapsone and clindamycin in patients of Acne Vulgaris over face.
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2023/11/059725
- Lead Sponsor
- Dr Jyoti Gadhvi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients having ISGA scoring of 1 or more at baseline.
Patients who are willing to take part in the study with signed and written informed consent.
Patients could be of both male and female.
All patients who are 15-45 years of age
Patient must be medically stable.
Patient must have active mobile number.
Pregnant, breast feeding, child bearing age using contraception.
Patient with nodulocystic lesions (ISGA Grade 4 and ISGA Grade 5) at the baseline.
Patient with a K/C/O any Autoimmune conditions like SLE, Thyroid disorder, Vitiligo, etc.
Patient receiving systemic treatment relevant to Facial Acne Vulgaris within 3 months of enrollment.
Patient receiving Topical treatment relevant to Facial Acne within 1 months
Patient who are on medications like topical facial antibiotics, topical acne medicines, topical corticosteroids within 2 weeks.
Patients who have undergone any facial procedures within 1 months.
Patients using any systemic retinoids or received treatment with estrogens or anti-androgenic agents within 2 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method